Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,107,985
-
Total 13F shares
-
13,566,970
-
Share change
-
+64,003
-
Total reported value
-
$61,458,813
-
Put/Call ratio
-
129%
-
Price per share
-
$4.53
-
Number of holders
-
48
-
Value change
-
+$897,363
-
Number of buys
-
13
-
Number of sells
-
36
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q3 2025
As of 30 Sep 2025,
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,566,970 shares.
The largest 10 holders included
BML Capital Management, LLC, Principia Wealth Advisory, LLC, Frazier Life Sciences Management, L.P., TCG Crossover Management, LLC, VANGUARD GROUP INC, 5AM Venture Management, LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Pale Fire Capital SE, and MILLENNIUM MANAGEMENT LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.